Nucleoside analog: Difference between revisions
Ostermayer (talk | contribs) m (Ostermayer moved page Nucleoside analogue to Nucleoside analoge) |
Ostermayer (talk | contribs) No edit summary |
||
| Line 1: | Line 1: | ||
==Mechanism of Action== | |||
*Nucleoside analoges are a class of antiviral medications that mimic the structure of natural nucleosides, interfering with viral DNA or RNA synthesis | |||
*Primarily used for treatment of herpesvirus infections (e.g., HSV, VZV), HIV, hepatitis B and C, and some other viral infections | |||
*Work by being incorporated into viral nucleic acids, leading to chain termination or mutagenesis | |||
==Adverse Effects== | |||
===Common=== | |||
*Nausea, vomiting, diarrhea | |||
*Headache, fatigue | |||
*Rash or pruritus | |||
*Bone marrow suppression (e.g., zidovudine) | |||
===Serious=== | |||
*Neurotoxicity (e.g., cidofovir, tenofovir) | |||
*Nephrotoxicity (e.g., acyclovir in renal impairment) | |||
*Lactic acidosis and hepatotoxicity (e.g., nucleoside reverse transcriptase inhibitors like zidovudine) | |||
*Bone density loss (e.g., tenofovir) | |||
*Teratogenicity (e.g., ribavirin contraindicated in pregnancy) | |||
{{#ask:[[Is DrugClass::nucleoside analoge]] |format=ul }} | {{#ask:[[Is DrugClass::nucleoside analoge]] |format=ul }} | ||
[[Category:Pharmacology]] | [[Category:Pharmacology]] | ||
Revision as of 15:41, 30 August 2025
Mechanism of Action
- Nucleoside analoges are a class of antiviral medications that mimic the structure of natural nucleosides, interfering with viral DNA or RNA synthesis
- Primarily used for treatment of herpesvirus infections (e.g., HSV, VZV), HIV, hepatitis B and C, and some other viral infections
- Work by being incorporated into viral nucleic acids, leading to chain termination or mutagenesis
Adverse Effects
Common
- Nausea, vomiting, diarrhea
- Headache, fatigue
- Rash or pruritus
- Bone marrow suppression (e.g., zidovudine)
Serious
- Neurotoxicity (e.g., cidofovir, tenofovir)
- Nephrotoxicity (e.g., acyclovir in renal impairment)
- Lactic acidosis and hepatotoxicity (e.g., nucleoside reverse transcriptase inhibitors like zidovudine)
- Bone density loss (e.g., tenofovir)
- Teratogenicity (e.g., ribavirin contraindicated in pregnancy)
